Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Recurrent SARS-CoV-2 mutations in immunodeficient patients

  • The COVID-19 Genomics UK (COG-UK) Consortium
  • Department of Medicine
  • University of Birmingham
  • Barts Health NHS Trust
  • Imperial College London
  • University of Portsmouth
  • Cardiff University
  • Public Health Wales
  • Nuffield Department of Medicine
  • King's College London
  • EaStCHEM School of Chemistry, University of Edinburgh
  • Guy’s and St Thomas’ NHS Foundation Trust
  • Wellcome Sanger Institute
  • Department of Medicine
  • UK Health Security Agency
  • University College London (UCL)
  • University College London Hospitals NHS Foundation Trust
  • Cambridge University Hospitals NHS Foundation Trust
  • University of Cambridge
  • University of Southampton
  • University Hospital Southampton NHS Foundation Trust
  • University College London
  • St. George's University of London
  • University of Brighton
  • St George’s University Hospitals NHS Foundation Trust
  • MRC-University of Glasgow Centre for Virus Research
  • Queen's University Belfast
  • Black-Pool Teaching Hospitals NHS Foundation Trust
  • Hull University Teaching Hospitals NHS Trust
  • University Hospitals Dorset NHS Foundation Trust
  • University Hospitals Sussex NHS Foundation Trust
  • University of Exeter
  • Belfast Health & Social Care Trust
  • University of Nottingham
  • East Kent Hospitals University NHS Foundation Trust
  • University of Kent
  • Northumbria University
  • University of Oxford
  • University of Sheffield
  • Portsmouth Hospitals University NHS Trust
  • NHS Lothian
  • NHS Greater Glasgow and Clyde
  • Quadram Institute
  • University of East Anglia
  • Hampshire Hospitals NHS Foundation Trust
  • Royal Free NHS Trust
  • South Tees Hospitals NHS Foundation Trust
  • Public Health Scotland
  • Health Services Laboratories
  • Heartlands Hospital
  • University of Liverpool
  • MRC Biostatistics Unit
  • Buckinghamshire Healthcare NHS Trust
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • University of St Andrews
  • Imperial College Healthcare NHS Trust
  • North West London Pathology
  • Betsi Cadwaladr University Health Board
  • University of Glasgow
  • Norfolk County Council
  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • Cardiff & Vale University Health Board
  • Norfolk and Norwich University Hospitals NHS Foundation Trust
  • Royal Brompton and Harefield NHS Foundation Trust
  • The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust
  • Whittington Health NHSTrust
  • Barking, Havering and Redbridge University Hospitals NHS Trust
  • Bournemouth University
  • Queens Medical Centre
  • University Hospitals of Leicester NHS Trust
  • County Durham and Darlington NHS Foundation Trust
  • Kettering General Hospital
  • Maidstone and Tunbridge Wells NHS Trust
  • Royal Oldham Hospital
  • North Cumbria Integrated Care NHS Foundation Trust
  • North Tees and Hartlepool NHS Foundation Trust
  • Northern Lincolnshire & Goole NHS Foundation Trust
  • University Hospitals Birmingham NHS Foundation Trust
  • Royal Devon and Exeter NHS Foundation Trust
  • Swansea University
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • Public Health Agency
  • Northumbria Healthcare NHS Foundation Trust
  • East Suffolk and North Essex NHS Foundation Trust
  • East Sussex Healthcare NHS Trust
  • Gateshead Health NHS Foundation Trust
  • Isle of Wight NHS Trust
  • King’s College Hospital NHS Foundation Trust
  • Liverpool Clinical Laboratories
  • Manchester University NHS Foundation Trust
  • North Middlesex University Hospital NHS Trust
  • Southwest Pathology Services
  • Royal Marsden NHS Foundation Trust
  • Royal Wolverhampton Hospitals NHS Trust
  • University of Birmingham
  • Watford General Hospital
  • Guy’s and St. Thomas’ Biomedical Research Centre
  • Newcastle University

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

84 Citas (Scopus)

Resumen

Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunodeficient patients are an important source of variation for the virus but are understudied. Many case studies have been published which describe one or a small number of long-term infected individuals but no study has combined these sequences into a cohesive dataset. This work aims to rectify this and study the genomics of this patient group through a combination of literature searches as well as identifying new case series directly from the COVID-19 Genomics UK (COG-UK) dataset. The spike gene receptor-binding domain and N-terminal domain (NTD) were identified as mutation hotspots. Numerous mutations associated with variants of concern were observed to emerge recurrently. Additionally a mutation in the envelope gene, T30I was determined to be the second most frequent recurrently occurring mutation arising in persistent infections. A high proportion of recurrent mutations in immunodeficient individuals are associated with ACE2 affinity, immune escape, or viral packaging optimisation.There is an apparent selective pressure for mutations that aid cell–cell transmission within the host or persistence which are often different from mutations that aid inter-host transmission, although the fact that multiple recurrent de novo mutations are considered defining for variants of concern strongly indicates that this potential source of novel variants should not be discounted.

Idioma originalInglés
Número de artículoveac050
PublicaciónVirus Evolution
Volumen8
N.º2
DOI
EstadoPublicada - 2022
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Recurrent SARS-CoV-2 mutations in immunodeficient patients'. En conjunto forman una huella única.

Citar esto